| P50 | author | Alexej Abyzov | Q41050187 |
| P2093 | author name string | Jeff Sloan | |
| | Charles L Loprinzi | |
| | Kathryn J Ruddy | |
| | Andreas S Beutler | |
| | Michaela S Banck | |
| | Rahul Kanwar | |
| | Amit A Kulkarni | |
| | Ganesh K Boora | |
| P2860 | cites work | Why most published research findings are false | Q21092395 |
| | Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance) | Q24289538 |
| | CONSORT statement: extension to cluster randomised trials | Q24604389 |
| | Ephrin-A5 and EphA5 Interaction Induces Synaptogenesis during Early Hippocampal Development | Q28574096 |
| | Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy | Q28943314 |
| | Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy | Q30399701 |
| | Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1. | Q34194773 |
| | Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline | Q34415239 |
| | Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies | Q34546292 |
| | Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy | Q34633385 |
| | Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1 | Q34866427 |
| | Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia | Q35148088 |
| | The ABCB1 3435 T allele does not increase the risk of paclitaxel-induced neurotoxicity | Q36216741 |
| | A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. | Q36243420 |
| | The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). | Q36341072 |
| | CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel | Q36862832 |
| | CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel | Q37055326 |
| | Eph receptors and ephrins in neuron-astrocyte communication at synapses | Q37919431 |
| | Detecting rare variant effects using extreme phenotype sampling in sequencing association studies | Q42109315 |
| | Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients | Q42969839 |
| | Relevance of nonsynonymous CYP2C8 polymorphisms to 13-cis retinoic acid and paclitaxel hydroxylation. | Q43084915 |
| | Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity | Q43496569 |
| | Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel | Q44439251 |
| | Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study | Q44554143 |
| | Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer | Q46163330 |
| | Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer | Q46958963 |
| | Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer. | Q50526560 |
| | Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer. | Q50557593 |
| | Chemotherapy-induced peripheral neurotoxicity | Q60750355 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | paclitaxel | Q423762 |
| P304 | page(s) | 631-9 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance) | |
| P478 | volume | 5 | |